Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more
Market Cap & Net Worth: Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016)
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (SHG:605016) has a market capitalization of $1.38 Billion (CN¥10.15 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #9654 globally and #2019 in its home market, demonstrating a -1.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s stock price CN¥24.17 by its total outstanding shares 420012320 (420.01 Million).
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Market Cap History: 2021 to 2026
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market capitalization history from 2021 to 2026. Data shows growth from $1.00 Billion to $1.38 Billion (18.47% CAGR).
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.84x
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap is 0.84 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
3.94x
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap is 3.94 times its annual earnings
5.50x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.00 Billion | $653.36 Million | $104.48 Million | 1.54x | 9.61x |
| 2022 | $869.86 Million | $721.89 Million | $150.75 Million | 1.20x | 5.77x |
| 2023 | $1.61 Billion | $868.26 Million | $193.00 Million | 1.85x | 8.32x |
| 2024 | $967.42 Million | $1.15 Billion | $245.60 Million | 0.84x | 3.94x |
Competitor Companies of 605016 by Market Capitalization
Companies near Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Historical Marketcap From 2021 to 2026
Between 2021 and today, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s market cap moved from $1.00 Billion to $ 1.38 Billion, with a yearly change of 18.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.38 Billion | +11.90% |
| 2025 | CN¥1.24 Billion | +27.81% |
| 2024 | CN¥967.42 Million | -39.74% |
| 2023 | CN¥1.61 Billion | +84.55% |
| 2022 | CN¥869.86 Million | -13.40% |
| 2021 | CN¥1.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.38 Billion USD |
| MoneyControl | $1.38 Billion USD |
| MarketWatch | $1.38 Billion USD |
| marketcap.company | $1.38 Billion USD |
| Reuters | $1.38 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.